Respiratory
Conditions
Interventions
furosemide group
placebo Group
Sponsors
hela Ben Turkia
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Age = 18 years Diagnosed with COPD GOLD 2023 :” Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles or gases and influenced by host factors including abnormal lung development” Presenting with COPD exacerbation Patients who can perform the measurement of FEV1.
Exclusion criteria
Exclusion criteria: - Hemodynamically instability (systolic blood pressure = 90mmHg) - Altered mental status. - Non-invasive mechanical ventilation or intubation at the time of recruitment - More than 6 liters of oxygen at the time of recruitment - Heart failure exacerbation - Hypokalemia - Hypersensitivity to furosemide - Patients that the final diagnosis is not COPD based on specific investigated at one month
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| -Improvement in forced expiratory volume in one second (FEV1) | — |
Secondary
| Measure | Time frame |
|---|---|
| - Change in arterial blood gases. - Change in dyspnea score (VAS) - Emergency department length of stay - Need of admission - Incidence of mortality | — |
Countries
Tunisia
Contacts
Public Contacthanene ghazali
professor
Outcome results
None listed